LATEST ARTICLES
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of the Bence-Jones protein.
An exploration of complementary therapies that help patients cope during and after treatment for cancer.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of Zollinger-Ellison syndrome.
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
Barbara Goff, MD, discusses ovarian cancer and how recognizing symptoms can lead to early detection and reduce misdiagnosis.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of Li-Fraumeni syndrome.
Growing evidence suggests that patients with cancer have better responses to the Moderna COVID-19 vaccine than to the Pfizer-BioNTech vaccine.
Researchers investigated how young adult cancer survivors felt about using medical crowdfunding to help cover their healthcare and basic living costs.
The new guidelines say there is insufficient evidence to support using aspirin to reduce colorectal cancer incidence or mortality.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of Lynch syndrome.
Women in academic medicine typically have lower starting salaries than men, and this disparity remains after 10 years on the job.
Of more than 2500 trials analyzed, 21% were randomized.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of HeLa cells.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of Waldenström macroglobulinemia.
Patients who have mismatch repair proficiency in the primary setting may have mismatch repair deficiency at recurrence.